We have demonstrated that neither CgA nor CgB level differed in type 2 diabetes patients from those in healthy controls, but serum CgB level was lower in the subgroup of type 2 diabetes patients with ICT. The gene discussed is CHGB; the disease is type 2 diabetes mellitus.